🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05244278
Recruiting Not applicable

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

NCT05244278 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2023-08-01
Last updated
2026-09-21

Condition(s) studied

Artificial Intelligence

Investigational drug(s) / intervention(s)

Medtronic-GI genius (CADe system for detecting colorectal polyps)

Medtronic-GI genius (CADe system for detecting colorectal polyps): Medtronic-GI genius: AI will provide real-time feedback throughout each colonoscopy procedure and alert endoscopists to the presence of a polyp in the endoscopy field by displaying a bounding box on the same screen.

Study summary

This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions.

The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.

Eligibility

Sex
ALL
Min age
45 Years
Max age
89 Years
Healthy volunteers
No
Inclusion Criteria: * indication of undergoing a screening, surveillance, or diagnostic colonoscopy * Age 45-89 years Exclusion Criteria: * Patients undergoing emergency colonoscopy * Patients with a known familial polyposis syndrome or a known inflammatory bowel disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier Universitaire de Montréal Montreal Quebec Recruiting

More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05244278 on ClinicalTrials.gov ↗ ← All trials in Canada